KalVista Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 11/14/2025 | 6.73 M | $81.96 M | 0.00% | 12.58% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 5.04 M | $61.41 M | 2.02% | 9.42% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 5.04 M | $61.39 M | 3.11% | 9.42% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 4.77 M | $58.08 M | -3.76% | 8.91% |
| CAPITAL WORLD INVESTORS | 11/13/2025 | 3.18 M | $38.70 M | 0.00% | 5.94% |
| BLACKROCK, INC. | 11/12/2025 | 3.13 M | $38.08 M | -0.11% | 5.84% |
| VANGUARD GROUP INC | 11/07/2025 | 2.50 M | $30.46 M | 3.68% | 4.68% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.10 M | $25.53 M | 515.40% | 3.92% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 2.00 M | $2.18 M | 100.00% | 3.74% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.92 M | $23.39 M | 0.00% | 3.59% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.80 M | $21.93 M | 1,239.44% | 3.37% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 1.74 M | $21.13 M | 155.50% | 3.24% |
| STATE STREET CORP | 11/14/2025 | 1.58 M | $19.19 M | 16.74% | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.36 M | $16.61 M | -25.59% | 2.55% |
| EMERALD ADVISERS, LLC | 10/30/2025 | 1.35 M | $16.46 M | 30.17% | 2.53% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 1.27 M | $15.51 M | 0.00% | 2.38% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 1.16 M | $14.14 M | 108.75% | 2.17% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 928.67 K | $11.31 M | -1.33% | 1.74% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/30/2025 | 917.98 K | $11.18 M | 19.38% | 1.72% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 864.60 K | $10.53 M | 100.00% | 1.62% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 750.00 K | $9.14 M | -83.96% | 1.40% |
| FREESTONE GROVE PARTNERS LP | 11/14/2025 | 704.45 K | $8.58 M | 100.00% | 1.32% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 683.82 K | $8.33 M | 100.00% | 1.28% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 606.17 K | $7.38 M | 100.00% | 1.13% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 596.47 K | $7.27 M | 454.16% | 1.12% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 581.60 K | $7.08 M | 100.00% | 1.09% |
| BARCLAYS PLC | 11/12/2025 | 577.90 K | $7.04 M | 242.11% | 1.08% |
| MORGAN STANLEY | 11/14/2025 | 564.86 K | $6.88 M | 135.72% | 1.06% |
| UBS GROUP AG | 11/13/2025 | 454.15 K | $5.53 M | 66.44% | 0.85% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 446.37 K | $5.44 M | 207.25% | 0.83% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 422.73 K | $5.15 M | -27.34% | 0.79% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 400.00 K | $4.87 M | 0.00% | 0.75% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 393.34 K | $4.79 M | 33.70% | 0.74% |
| MARSHALL WACE, LLP | 11/13/2025 | 370.77 K | $4.52 M | 209.95% | 0.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 364.41 K | $4.44 M | -0.70% | 0.68% |
| NORTHERN TRUST CORP | 11/14/2025 | 350.72 K | $4.27 M | -0.41% | 0.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 325.44 K | $3.96 M | 234.64% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 321.97 K | $3.92 M | 183.68% | 0.60% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 286.88 K | $3.49 M | 100.00% | 0.54% |
| CITIGROUP INC | 11/10/2025 | 280.66 K | $3.42 M | -6.20% | 0.52% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2025 | 200.99 K | $2.45 M | 391.87% | 0.38% |
| F/M INVESTMENTS LLC | 11/13/2025 | 199.20 K | $2.43 M | 9.30% | 0.37% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 197.34 K | $2.40 M | -32.56% | 0.37% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 176.58 K | $2.15 M | 13.22% | 0.33% |
| NAN FUNG TRINITY (HK) LTD | 11/04/2025 | 154.52 K | $1.88 M | 0.00% | 0.29% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 149.31 K | $1.82 M | 47.78% | 0.28% |
| SUMMITTX CAPITAL, L.P. | 11/14/2025 | 143.56 K | $1.75 M | 100.00% | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 142.90 K | $1.74 M | 0.00% | 0.27% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 141.42 K | $1.72 M | 100.00% | 0.26% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 128.01 K | $1.56 M | 38.75% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
KalVista Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 193 institutional investors and hedge funds held shares of KalVista Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VR Adviser, LLC: 6.73 M
TANG CAPITAL MANAGEMENT LLC: 5.04 M
Frazier Life Sciences Management, L.P.: 5.04 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 4.77 M
Capital World Investors: 3.18 M
BlackRock, Inc.: 3.13 M
113.34% of KalVista Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 66.41 M shares in the last 24 months. This purchase volume represents approximately $786.94 M in transactions.